美股A股
StockGist
Back
8-K2026-03-09· grok-4-1-fast-non-reasoning

ZVRA · Zevra Therapeutics, Inc.

0001434647-26-000009

SEC filing

Summary

Zevra Therapeutics, Inc. issued a press release on March 9, 2026 regarding results of operations and financial condition. The filing also discloses an employment agreement effective March 9, 2026 with Justin Renz and an executive change on March 4, 2026.

Key takeaways